- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 8, 2026 | 18.31M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 18.06B sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 17.35B sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 13.21B sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 12.29B sh |
| Capex | Q3 2026 · Mar 31, 2026 | $439K |
| Capex restated | Q3 2026 · Mar 31, 2025 | $85K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$1.64M |
| Operating Cash Flow restated | Q3 2026 · Mar 31, 2025 | −$1.08M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $37.78M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $3.63M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $40.09M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $40.8M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $17.9M |
| Stockholders Equity restated | Q3 2026 · Mar 31, 2025 | $18M |
| Stockholders Equity restated | Q3 2026 · Dec 31, 2024 | −$1.03M |
| Stockholders Equity restated | Q3 2026 · Jun 30, 2024 | $2.28M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $1.54M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $705K |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $2.43M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $1.51M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $40.17M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $17.34M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $42.52M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $19.41M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.10 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.30 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.11 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.18 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.10 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.30 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.12 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.18 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $1.63M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $4.84M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $1.31M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $2.29M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $882K |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $2.39M |
| Rd Expense restated | Q3 2026 · Mar 31, 2025 | $471K |
| Rd Expense restated | Q3 2026 · Mar 31, 2025 | $1.13M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$1.8M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$5.15M |
| Net Income restated | Q3 2026 · Mar 31, 2025 | $1.46M |
| Net Income restated | Q3 2026 · Mar 31, 2025 | −$2.16M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$3.35M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$9.69M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$2.09M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$4.52M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $836K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $2.46M |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $311K |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $1.11M |
| Revenue | Q3 2026 · Mar 31, 2026 | $1.22M |
| Revenue | Q3 2026 · Mar 31, 2026 | $3.88M |
| Revenue restated | Q3 2026 · Mar 31, 2025 | $1.26M |
| Revenue restated | Q3 2026 · Mar 31, 2025 | $3.35M |
| Short Term Debt | Q3 2026 · Aug 31, 2024 | $3.1M |